Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Illudin S is a cytotoxic illudin that is converted, intracellularly, to metabolites that cause a complete block of cell cycling at the G1-S phase interface, particularly in myeloid and T-lymphocyte leukemia cells (IC50 = 6-11 nM).1 T-lymphocyte leukemia CEM cells that are resistant to doxorubicin (Item No. 15007), epipodophyllotoxins, and 1-β-D-arabinofuranosylcytosine display only 2-fold increased resistance to illudin S.1 Illudin S metabolites induce DNA damage that is not repaired by the processes that counter conventional DNA alkylating agents.2,3,4
WARNING This product is not for human or veterinary use.
1. Preclinical evaluation of illudins as anticancer agents. Cancer Res. 47(12), 3186-3189 (1987).
2. Anticancer active illudins: Recent developments of a potent alkylating compound class. Curr. Med. Chem. 18, 790-807 (2011).
3. Characterization of illudin S sensitivity in DNA repair-
4. Anti-